Salute e Benessere

Publication Relating to a Transparency Notification

REGULATED INFORMATIONPublication Relating to a Transparency NotificationMont-Saint-Guibert(Belgium), December 8, 2023, 10.30pm CET / 4.30pm ET –In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below.On December 6, 2023, Nyxoah received a transparency notification from Deerfield Partners, L.P...
Nasdaq GlobeNewswire
08/12/2023

Roche's Kadcyla is the first targeted therapy to show significant overall…

Phase III KATHERINE results reinforce Kadcyla as the standard of care for this population, with more than 82,000 people treated to date 1,2 Long-term data also showed continued benefit in invasive disease-free survival for adjuvant Kadcyla compared to Herceptin in this study 2 These data will be presented as an oral presentation at the 2023 San Antonio Breast Cancer Symposium and included in the official press programme Basel, 8 December 2023 - Roche (SIX: RO, ROG; OTCQX:...
Nasdaq GlobeNewswire
08/12/2023

Roche's inavolisib combination reduces the risk of disease progression by 57% in…

Inavolisib in combination with palbociclib and fulvestrant more than doubled progression-free survival compared to palbociclib and fulvestrant alone1The inavolisib combination has the potential to address resistance to treatment and poor prognosis associated with PIK3CA mutations 2-5These new data are being presented today in an oral presentation at the 2023 San Antonio Breast Cancer Symposium and shared with health authoritiesBasel, 8 December 2023 - Roche (SIX: RO, ROG;...
Nasdaq GlobeNewswire
08/12/2023

Groupe Casino - Nombre de droits de vote et d'actions au 30-11-2023

CASINO, GUICHARD-PERRACHON Société anonyme au capital de 165 892 131,90 € Siège social : 1, Cours Antoine Guichard 42000 Saint-Etienne 554 501 171 R.C.S. Saint-Etienne Informations relatives au nombre total de droits de vote et d'actions composant le capital social au 30 novembre 2023(article 223-16 du Règlement Général de l'Autorité des Marchés Financiers)Nombre d'actions composant le capitalNombre total de droits de voteNombre total de droits de vote exerçables en...
Nasdaq GlobeNewswire
08/12/2023

STORM Therapeutics' First-in-Class tRNA methyltransferase inhibitor of METTL1 to…

Preclinical data demonstrated that: Preclinical data demonstrated that: Jerry McMahon, Chief Executive Officer & President of STORM Therapeutics, said: "It is very exciting to be able share for the first time that inhibition of the tRNA methyltransferase METTL1 with a small molecule shows anti-cancer properties. We continue to expand our pipeline of novel and proprietary chemistries to modulate enzymes which modify RNA. We look forward to advancing our first-in-class METTL1 program...
PR Newswire
08/12/2023

Sanitary Ware Market to Reach $15.9 Billion, Globally, by 2032 at 6.1% CAGR…

Request Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/3841 Request Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/3841 Prime determinants of growth The sanitary ware market is primarily driven by remodeling and renovation initiatives. However, the market for sanitary ware is significantly constrained by high installation costs. On the other hand, smart technology integration is creating lucrative opportunities for the...
PR Newswire
08/12/2023

Robotic Lawn Mower Market to Reach $2.4 Billion, by 2032 at 10.9% CAGR: Allied…

Request Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/5117 Request Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/5117 Prime determinants of growth The robotic lawn mower market is driven by factors such as increase in demand for automation, rise in advancements for technology, and increase in popularity of online platforms. However, the rise in regular maintenance and repair costs restricts market growth. Moreover, the...
PR Newswire
08/12/2023

Telehealth & Telemedicine Market Worth $285.7 Billion | MarketsandMarkets

57 - Tables134 - Figures163 - Pages 57 - Tables 134 - Figures 163 - Pages Telehealth & Telemedicine Market Scope: Software and services segment is expected to register the substantial share by component of Telehealth and telemedicine market In 2022, the largest market share, accounting for 71.3%, was held by the Software and services segment. This dominance is attributed to the increasing demand for telehealth applications, particularly in real-time monitoring...
PR Newswire
08/12/2023

In Vitro Diagnostics Market Size Estimated to Reach USD 124.65 Bn by 2032|…

The North America in vitro diagnostics (IVD) marketsize was estimated at USD 48.98 billion in 2022 and is projected to reach around USD 50.29 billion by 2032, with a CAGR of 1.1% between 2023 and 2032. The North Americain vitro diagnostics (IVD) marketsizewas estimated atUSD 48.98 billionin 2022 and is projected to reach aroundUSD 50.29 billionby 2032, with a CAGR of 1.1% between 2023 and 2032. The Europein vitro diagnostics (IVD) market sizewas valued atUSD 30...
PR Newswire
08/12/2023

Home Insecticides Market to Reach $31.1 Billion, Globally, by 2032 at 7.5% CAGR…

Prime determinants of growth Prime determinants of growth The global household insecticides market is experiencing growth due to several factors such as increase in government initiatives promoting the use of insecticides in households and a surge in awareness of health and hygiene among consumers. However, the availability of alternative pest control methods hinders market growth to some extent. Moreover, advancement in insecticide release technologies offers remunerative opportunities...
PR Newswire
08/12/2023

Active Pharmaceutical Ingredients Market to Surpass $372.4 Billion, Globally, by…

Request Sample Copy of this Report: https://www.coherentmarketinsights.com/insight/request-sample/738 Request Sample Copy of this Report: https://www.coherentmarketinsights.com/insight/request-sample/738 Market Drivers: The rise in the prevalence of various infectious diseases and chronic disorders Among product type, the high potent APIs segment is expected to witness the fastest growth in the globalactive pharmaceutical ingredients (API) market over the forecast...
PR Newswire
08/12/2023

Menarini Group Presents New Progression-Free Survival Data from EMERALD Clinical…

Importantly, a prior post hoc subgroup analysis of the EMERALD PFS results, which was presented at SABCS 2022, demonstrated that the duration of prior CDK4/6 inhibitor treatment was positively associated with longer PFS on ORSERDU but not with SOC. For patients with ESR1 mutations who were treated with CDK4/6 inhibitors for at least 12 months prior to randomization on EMERALD, ORSERDU achieved a median PFS of 8.6 months versus 1.9 months on SOC, with a 59% reduction in the risk of progression or…
PR Newswire
08/12/2023

Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of…

With 5.6 months of additional follow-up and 78.3% of patients having completed Kisqali ®(ribociclib) investigational treatment, the updated analysis shows sustained iDFS benefitand stability in secondary endpoints including overall survival (OS) 1,2 iDFS benefit remains consistent across key patient subgroups; among patients with stage II and stage III tumors, Kisqali lowered risk by 30% and 24.5%, respectively 1,2Latest analysis continues to show a...
Nasdaq GlobeNewswire
08/12/2023

U.S. Institute of Peace Announces Pétronille Vaweka the 2023 Women Building…

"Pétronille is a woman of courage and determination," said Lise Grande, USIP's president and CEO. "Pétronille negotiates, persuades, influences, and inspires people to lay down their weapons, end fighting, and work together to resolve their grievances. This is some of the hardest, most dangerous work done by anybody anywhere." "Pétronille is a woman of courage and determination," said Lise Grande , USIP's president and CEO. "Pétronille negotiates, persuades…
PR Newswire
08/12/2023

BBS-Bioactive Bone Substitutes Plc: Managers' Transactions – Jarmo Halonen

BBS-Bioactive Bone Substitutes Plc, Company announcement, Management transactions, 8 December 2023 at 3.30 p.m. (EET)BBS-Bioactive Bone Substitutes Oyj - Managers' Transactions – Jarmo Halonen ____________________________________________Person subject to the notification requirement Name: Halonen Jarmo Position: Member of the Board/Deputy member Issuer: BBS Bioactive Bone Substitutes OyjLEI: 743700BYSBP0PCR6N767 Notification type: INITIAL NOTIFICATION Reference number:...
Nasdaq GlobeNewswire
08/12/2023

BBS-Bioactive Bone Substitutes Plc: Managers' Transactions – Oili Halonen

BBS-Bioactive Bone Substitutes Plc, Company announcement, Management transactions, 8 December 2023 at 3.30 p.m. (EET)BBS-Bioactive Bone Substitutes Oyj - Managers' Transactions – Oili Halonen ____________________________________________Person subject to the notification requirement Name: Halonen Oili Position: Closely associated person (1):Person Discharging Managerial Responsibilities In Issuer Name: Halonen Jarmo Position: Member of the Board Issuer: BBS Bioactive Bone Substitutes...
Nasdaq GlobeNewswire
08/12/2023

uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

uniQure N.V.(NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the grant of inducement equity awards to newly hired employees.The company granted equity awards to 28 employees as a material inducement to commencing their employment. In the aggregate, those employees received 142,300 restricted share units and options to purchase 52,500 ordinary shares of the company. Each option has an exercise price of...
Nasdaq GlobeNewswire
08/12/2023

New Israeli cannabis regulation, facilitating access for many new patients…

In addition to the regulatory reform, the Medical Cannabis Unit of the Ministry of Health released new report that shows, among other statistics, data on the number of patients obtaining medical cannabis licenses. There was a notable surge in the number of new medical cannabis patients in November 2023, with 3,254 new patients receiving licenses, the largest increase in new patients per month since 2021. In addition to the regulatory reform, the Medical Cannabis Unit of the Ministry of Health...
PR Newswire
08/12/2023

Chromatography Consumables and Chromatography Instrumentation Market Size to…

Chromatography Consumables and Chromatography Instrumentation Market Report Scope Chromatography Consumables and Chromatography Instrumentation Market Report Scope Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/2011 The chromatography technique separates, identifies, and purifies the complex samples. This process involves the distribution of each analyte between the mobile phase (liquid/gas) and stationary phase (solid/liquid). Chromatography...
PR Newswire
08/12/2023

Global Bispecific Antibody Therapeutics Contract Manufacturing Market Size to…

Bispecific Antibody Therapeutics Contract Manufacturing Market Report Scope Bispecific Antibody Therapeutics Contract Manufacturing Market Report Scope Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1996 Bispecific antibody drugs have unique biological and pharmacological characteristics and are available in various formats, making them beneficial for therapeutic use. The surging pipeline of bispecific antibodies and the rising number of related...
PR Newswire
08/12/2023

Cardiac AI Monitoring and Diagnostics Market Size to Expand Lucratively and…

Cardiac AI Monitoring and Diagnostics Market Report Scope Cardiac AI Monitoring and Diagnostics Market Report Scope Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1952 The future of cardiology will depend on many new technologies, including artificial intelligence (AI), precision medicine and the Internet of Things (IoT). AI/ML has increasingly been used to detect and diagnose cardiac diseases. Cardiac AI monitoring and diagnosis include using...
PR Newswire
08/12/2023

Automated Liquid Handling Technologies Market Size to Expand Lucratively and…

Automated Liquid Handling Technologies Market Report Scope Automated Liquid Handling Technologies Market Report Scope Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1934 The technological advancements in the life science industry have helped drive the best results of a product in terms of throughput, efficiency, and frequency. Due to the increasing demand for biopharmaceuticals, the number of laboratories worldwide providing analytical and...
PR Newswire
08/12/2023

Cosmetics Market to Reach $864.6 Billion, Globally, by 2032 at 7.1% CAGR: Allied…

Request Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/651 Request Sample Copy of Report:https://www.alliedmarketresearch.com/request-sample/651 Prime determinants of growth The rise in the need for skin care products is driving the growth of the cosmetics market. However, the market for cosmetics is significantly constrained by regulatory compliance. On the other hand, the growth in demand for organic cosmetics is creating lucrative opportunities...
PR Newswire
08/12/2023

Updated clinical safety and efficacy data for iOnctura's roginolisib presented…

Mass cytometry data showed treatment with roginolisib led to an increase in activated anti-cancer CD8+ T-cells and natural killer (NK) cells, increased interferon signalling and a decrease in cancer-promoting Regulatory T-cells. This shifts the balance of the immune system enabling a more-effective attack on cancer. Boosting of antitumoral immunity was observed in patients with long-term disease control after roginolisib treatment but not patients with progressive disease. Mass cytometry…
PR Newswire
08/12/2023
Altri  Comunicati